ALB and metabolic dysfunction-associated steatotic liver disease: Even though none of the NAFLD or hepatitis patients had yet developed cirrhosis and there were no significant changes in their serum albumin levels in comparison to the healthy people, their TBS values had already shown various degrees of decline.